Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20542 | 394 | 29.1 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PEPTIDE PROT CHEM | Address | 10 | 29% | 7% | 29 |
| 2 | PHYSICOCHEM UNIT | Address | 7 | 64% | 2% | 7 |
| 3 | QUIM PEPTIDS PROT | Address | 6 | 50% | 2% | 8 |
| 4 | BRANCHED PEPTIDES | Author keyword | 4 | 42% | 2% | 8 |
| 5 | MULTIPLE ANTIGENIC PEPTIDE | Author keyword | 4 | 38% | 2% | 9 |
| 6 | EPITOPE SPECIFIC SUPPRESSION | Author keyword | 4 | 75% | 1% | 3 |
| 7 | MULTIPLE ANTIGENIC PEPTIDE MAP | Author keyword | 4 | 75% | 1% | 3 |
| 8 | PHOSPHOLIPID MODEL MEMBRANES | Author keyword | 4 | 75% | 1% | 3 |
| 9 | POLYOXIME | Author keyword | 4 | 75% | 1% | 3 |
| 10 | MULTIPLE ANTIGEN PEPTIDE | Author keyword | 3 | 27% | 3% | 11 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIPEPTIDE | 8 | 75% | 2% | 6 |
| 2 | MAP SYSTEM | 7 | 67% | 2% | 6 |
| 3 | BRANCHED PEPTIDES | 6 | 47% | 2% | 9 |
| 4 | MULTIPLE ANTIGENIC PEPTIDE | 4 | 67% | 1% | 4 |
| 5 | MULTIPLE ANTIGEN PEPTIDE | 3 | 29% | 3% | 10 |
| 6 | HYPERVARIABLE EPITOPE CONSTRUCTS | 3 | 57% | 1% | 4 |
| 7 | INDUCED EPITOPIC SUPPRESSION | 3 | 27% | 3% | 10 |
| 8 | MULTIPLE ANTIGEN PEPTIDES | 3 | 35% | 2% | 6 |
| 9 | DEFINED SYNTHETIC VACCINE | 2 | 38% | 1% | 5 |
| 10 | BRANCHED NEUROTENSIN PEPTIDES | 2 | 67% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Recent advances in multiple antigen peptides | 1996 | 114 | 86 | 30% |
| Peptide and glycopeptide dendrimers. Part I | 1999 | 56 | 149 | 23% |
| Multiple antigen peptide system | 1997 | 24 | 30 | 47% |
| Dendrimers for Vaccine and Immunostimulatory Uses. A Review | 2010 | 36 | 70 | 23% |
| Peptide dendrimers | 2005 | 62 | 160 | 14% |
| Branched Peptides as Therapeutics | 2008 | 32 | 77 | 18% |
| Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept | 2010 | 11 | 29 | 31% |
| Design of synthetic peptidic constructs for the vaccine development against viral infections | 2004 | 18 | 93 | 19% |
| Different Approaches to Potentiate the Immune Response Induced by a 12-Mer Synthetic Peptide | 2000 | 6 | 60 | 50% |
| Design of peptide and polypeptide vaccines | 1997 | 64 | 56 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEPTIDE PROT CHEM | 10 | 29% | 7.4% | 29 |
| 2 | PHYSICOCHEM UNIT | 7 | 64% | 1.8% | 7 |
| 3 | QUIM PEPTIDS PROT | 6 | 50% | 2.0% | 8 |
| 4 | PEPTIDES | 3 | 25% | 2.8% | 11 |
| 5 | VACUNAS | 1 | 19% | 1.5% | 6 |
| 6 | EIJKMAN WINKLER MICROB INFECT DIS INFLAMM | 1 | 50% | 0.3% | 1 |
| 7 | HI TECH COURT 3 | 1 | 50% | 0.3% | 1 |
| 8 | UNITAT FISICOQUIM | 1 | 18% | 0.8% | 3 |
| 9 | CHIM BIOORGAN PHARM | 0 | 33% | 0.3% | 1 |
| 10 | PEPTIDS | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000293774 | AK TUMORIMMUNOL VAKZINE//MALP 2//N ELECTROPHILIC AMINATION |
| 2 | 0.0000160340 | PREDETERMINED SPECIFICITY//SYNTHETIC ANTIGENIC SITE//B CELL EPITOPE PREDICTION |
| 3 | 0.0000135028 | FUSOGENIC LIPIDS//DRUG DELIVERY SYST DEV//B30 MDP |
| 4 | 0.0000097199 | CIRCUMSPOROZOITE PROTEIN//RTS S//MALARIA PROGRAM |
| 5 | 0.0000094203 | GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP |
| 6 | 0.0000085441 | ISCOMS//ISCOM//QUIL A |
| 7 | 0.0000084704 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |
| 8 | 0.0000068870 | BIO NANOCAPSULE//RECOMBINANT HEPATITIS B SURFACE ANTIGEN//PRE S1 |
| 9 | 0.0000061928 | HYDRATE SHELLS//CHRONIC TOXIC HEPATITIS//PHOSPHATIDYLCHOLINE MEMBRANE |
| 10 | 0.0000060389 | INVARIANT CHAIN//HLA DM//ANTIGEN PROCESSING |